| | 503612-47-3 Basic information More.. |
| Product Name: | Apixaban | | Synonyms: | Apixaban;Apixaban, BMS 562247-01;BMS 562247-01;1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid aMide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,
5-dihydropyrazolo[3,4-c]pyridine-3-carboxaMide;Nilotinib and its interMediate;Apixaban ,ELIQUIS;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide Apixaban | | CAS: | 503612-47-3 | | MF: | C25H25N5O4 | | MW: | 459.5 | | EINECS: | 639-684-6 | | Mol File: | 503612-47-3.mol |  |
Use
Apixaban is a new form of oral anticoagulant drug developed by Bristol Myers Squibb and Pfizer. It is a new form of oral Xa factor inhibitor, and its commercial name is Eliquis. Apixaban is used to treat adult patients undergoing elective hip or knee replacement surgery to prevent venous thromboembolism (VTE).
- Apixaban
-
- US $2.00 / kg
- 2024-04-26
- CAS:503612-47-3
- Min. Order: 1kg
- Purity: 99.5%
- Supply Ability: 200kgs
- Apixaban
-
- US $100.00-60.00 / kg
- 2024-04-26
- CAS:503612-47-3
- Min. Order: 100kg
- Purity: 99.99%
- Supply Ability: 100Tons
|
|
503612-47-3
Recommend Suppliers |
|